Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0

PURPOSE: Investigate in patients with metastatic and/or irresectable colorectal cancer treated with systemic treatment with capecitabine or TAS-102 whether: 1. Intestinal microbiota composition can act as a predictor for response. 2. Intestinal microbiota composition changes during systemic treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Aarnoutse, R., de Vos-Geelen, J. M. P. G. M., Penders, J., Boerma, E. G., Warmerdam, F. A. R. M., Goorts, B., Olde Damink, S. W. M., Soons, Z., Rensen, S. S. M., Smidt, M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Clinical Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486633/
https://www.ncbi.nlm.nih.gov/pubmed/28444508
http://dx.doi.org/10.1007/s00384-017-2819-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486633/
https://www.ncbi.nlm.nih.gov/pubmed/28444508
http://dx.doi.org/10.1007/s00384-017-2819-3

Ejemplares similares